British Minister Proposes Trial of Waste Injections for Unemployed Individuals with Obesity

united kingdom - The British Minister suggests a plan to administer waste injections for overweight unemployed individuals. Is this a good plan and what are the costs involved?

Unemployed overweight individuals could potentially undergo waste injections as part of a trial proposed by a British Minister. This initiative aims to address the increasing costs associated with obesity, surpassing those of smoking. Data suggests that overweight employees already working tend to report an average of four extra sick days per year, with a forecast indicating a 50% rise in the number of obese workers on long-term sick leave in England over the next five years.

The Minister has chosen Mounjaro from Lilly, containing the active ingredient Tirzepatide, over competing options like Wegovy and Ozempic, citing potentially better outcomes. Previous trials resulted in patients losing an average of 21% of their body weight over 36 weeks. The estimated monthly cost for these injections is over 140 euros.

The trial, set to take place in the Manchester region, is projected to run for five years and lead to billions in healthcare savings. Participants will be required to enhance their physical activity and adopt healthier eating habits. It is worth noting that obesity currently affects 1 in 8 individuals globally, leading to health issues for 2.5 billion people, making it the fifth leading cause of death.

Comparatively, the prevalence of obesity in the Netherlands is relatively low, standing at 16% of the population in 2023. In contrast, England already has a rate of around 25%.